Caribou Biosciences (CRBU) Revenue (2020 - 2026)
Caribou Biosciences (CRBU) posted quarterly Revenue of $2.4 million for Q1 2026, up 1.87% year-over-year from $2.4 million in Q1 2025, and down 39.18% quarter-over-quarter from $3.9 million in Q4 2025.
Caribou Biosciences (CRBU) Revenue (2020 - 2026) Analysis & Trends
Caribou Biosciences (CRBU) has reported Revenue for 7 consecutive years, with $2.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Revenue rose 1.87% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at $11.2 million (up 12.96% YoY), while the FY2025 annual figure was $11.2 million, up 11.66% from the prior year.
- Revenue fell to $2.4 million in Q1 2026 per CRBU's latest filing, from $3.9 million in the prior quarter.
- Across five years, Revenue topped out at $23.7 million in Q3 2023 and bottomed at $2.0 million in Q3 2024.
- Historically, Revenue has averaged $4.2 million across 5 years, with a median of $3.3 million in 2022.
- Annual changes were most pronounced in 2023 — Revenue jumped 616.38% — and 2024, when it tumbled 91.45%.
- Caribou Biosciences' Revenue stood at $3.7 million in 2022, then decreased by 3.63% to $3.6 million in 2023, then plunged by 41.62% to $2.1 million in 2024, then surged by 89.74% to $3.9 million in 2025, then slumped by 39.18% to $2.4 million in 2026.
- Business Quant data shows CRBU's Revenue at $2.4 million in Q1 2026, $3.9 million in Q4 2025, and $2.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.60 Bn | 130.75 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.93 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 65.06 Bn | 59.88 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 56.22 Bn | 51.08 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 31.65 Bn | 28.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | 1.06 Bn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 425.49 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - | 674.14 Mn |
| 10 | Caribou Biosciences | 168.56 Mn | 56.24 Mn | - | 1.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.50 Mn |
| Mar 31, 2026 | 2.40 Mn |
| Dec 31, 2025 | 3.94 Mn |
| Sep 30, 2025 | 2.20 Mn |
| Jun 30, 2025 | 2.67 Mn |
| Mar 31, 2025 | 2.35 Mn |
| Dec 31, 2024 | 2.08 Mn |
| Sep 30, 2024 | 2.02 Mn |
| Jun 30, 2024 | 3.46 Mn |
| Mar 31, 2024 | 2.43 Mn |
| Dec 31, 2023 | 3.56 Mn |
| Sep 30, 2023 | 23.66 Mn |
| Jun 30, 2023 | 3.76 Mn |
| Mar 31, 2023 | 3.50 Mn |
| Dec 31, 2022 | 3.69 Mn |
| Sep 30, 2022 | 3.30 Mn |
| Jun 30, 2022 | 4.19 Mn |
| Mar 31, 2022 | 2.66 Mn |
| Dec 31, 2021 | 2.56 Mn |
| Sep 30, 2021 | 3.98 Mn |